Details

Last Funding Type

Series A

Last Funding Money Raised

$2.30M

Industries

Biotechnology,Pharmaceutical,Therapeutics

Founded date

Jan 1, 2016

Number Of Employee

1 - 10

Operating Status

Active

Upside is developing the most advanced and best treatment for severe burns. The Upside product is a regenerative medicine solution to current shortcomings in the current treatment of severe burns patients. Upside will take a small sample of unburnt patient skin and grow it into differentiated, graftable skin in order to cover the patient’s own burns.
Product advantages are that Upside's engineered skin is produced faster than any competitive pipeline product, it is supplied in bigger sheets and has good handling characteristics. Upside has intellectual property covering the processes conferring these specific advantages.